Ondansetron Tablet, Orally Disintegrating
Product Images NDC 43063-857

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 43063-857). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063857)

This is a medication called Ondansetron which comes in tablet form with each tablet containing 4mg of the orally disintegrating drug. The recommended dosage is to take it 2 times a day and any side effects should be reported to the FDA. People who experience any side effects should call a doctor for medical advice. There is also a warning that it should be kept out of reach of children. The package insert includes reorder numbers, lot numbers and an expiration date of 02/2024.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.